ID.1
Item
adult patients, >/=18 years of age
boolean
ID.2
Item
diagnosis of breast carcinoma with her-2 overexpression
boolean
ID.3
Item
at least one measurable brain metastasis
boolean
ID.4
Item
patients for whom, according to investigator assessment, whole brain radiotherapy is the best therapeutic option
boolean
ID.5
Item
performance status (who) </=2
boolean
ID.6
Item
life expectancy >/=3 months
boolean
ID.7
Item
presence of neoplastic meningitis
boolean
ID.8
Item
any prior radiotherapy to the brain
boolean
ID.9
Item
patients for whom, according to investigator assessment, stereotactic radiotherapy is the best therapeutic option
boolean
ID.10
Item
previous neoplasms, other than breast carcinoma, within 5 years since enrolment
boolean